Vorpal Technologies offers a full range of regulatory, reimbursement, D-MAH services and commercialization programs in Japan for innovative healthcare companies.
Vorpal acts as a virtual subsidiary, enabling pharmaceutical, medical device and IVD companies to enter Japan quickly and economically while maintaining control of their marketing authorizations.

Vorpal’s First Class Medical Devices Marketing License (No. 13B1X10172) is renewed with validity through 2023.

>> Learn more

What's New

Vorpal is pleased to welcome Tak Ito as General Manager with extensive experience in the healthcare industry.
Tak started his career in the auto industry with Nissan Motor Co. and experienced the initial phase of the partnership with Renault. Since his move to the healthcare industry, he has 15 years of experience in the commercial arena with Eli Lilly, Novo Nordisk and Baxter. His experience ranges from CNS, Diabetes and Anesthesia on the pharmaceutical side to surgical specialties in Spine, CV and Neuro. Tak was born in the US and has lived in Japan for 30 years since moving there after High School.
Effective September 25, 2018, Vorpal Technologies will relocate to new premises as follows.

Daini Yanagiya Building 7F, 1-12-8, Nihonbashi, Chuo-ku, Tokyo 103-0027
Tel No. +81-3-5544-8340  Fax No. +81-3-5544-8653
Nearest Station: Tokyo Metro Nihonbashi Station. 30 seconds walk from D4 exit
Google Map
Vorpal Technologies And Shanghai Medbridge Medical Technology Group Announce Partnership to Accelerate Market Access for MedTech Innovations
Click here for more information
Vorpal Technologies K.K., a leading company in new category medical device approvals and virtual subsidiary operations for medtech innovators, has agreed on a business collaboration with Shanghai Medbridge a China-wide medical device distributor and vertically-integrated service provider, in order to realize business synergies and expand market access for clients. MedBridge targets to bring in new innovative clients to China from Japanese medical device companies as well as Vorpal’s overseas client companies. Another target is to help Japanese companies who are already approved and selling in China to optimize their market penetration by being a better partner.
“I am proud to announce that Vorpal and Medbridge have come together to be a seamless gateway to Japan and China for medtech innovators,” said Robert E. Claar, CEO of Vorpal Technologies. “Medbridge can offer regulatory, market assessment, exhibitions and investor forums in addition to their core nationwide distribution services. Partnership with Medbridge enables Vorpal to support our clients as they consider entering the China market.”

About Shanghai Medbridge Medical Technology Group
Shanghai MedBridge Medical Technology Group (MedBridge Group) is a multi-service provider in China's medical industry. Medbridge offers a full range of solutions including business consulting, medical device distribution, exhibitions and 3rd party logistics. With decades of experience in the medical industry, Medbridge are experts in medtech business incubation (since 2004) and medical device distribution services (since 2009). The Medbridge network exceeds 1,500 distributors and covers 27 provinces in China and has distribution network for Southeast Asia.

Professional background:
- Diverse multinational corporate experience, such as Johnson & Johnson, Medtronic and Stryker.
- Well established working relationships with the Government of China.
- Experts in medical industry policy & market development outlook.

For more information please visit: http://www.medbridge.com.cn/en/

See more

Banner Why Vorpal?

Vorpal is a proud member of the following association

AMSS Banner

American Medical Devices and Diagnostics Manufacturers' Association (AMDD)